Penicillin derivatives
    1.
    发明授权
    Penicillin derivatives 失效
    青霉素衍生物

    公开(公告)号:US4668514A

    公开(公告)日:1987-05-26

    申请号:US658373

    申请日:1984-10-05

    摘要: This invention provides a penicillin derivative of the formula ##STR1## wherein R.sub.1 and R.sub.2 are the same or different and represent hydrogen, C.sub.1-6 alkyl, C.sub.1-6 hydroxyalkyl, C.sub.3-9 acyloxyalkyl, C.sub.8-13 benzyloxyalkyl, C.sub.2-7 alkoxyalkyl, C.sub.2-7 alkoxycarbonyl, C.sub.3-8 alkenyloxycarbonyl, C.sub.3-8 alkynyloxycarbonyl, phenyl, amino, cyano, formyl, trifluoromethyl, C.sub.2-6 acyl, carbamoyl, C.sub.2-7 alkylcarbamoyl, benzyloxycarbonylamino, C.sub.2-7 alkoxycarbonylamino; and R.sub.3 is hydrogen, a group for forming a pharmaceutically acceptable salt, or a penicillin carboxyl protecting group, with the proviso that both of R.sub.1 and R.sub.2 are not hydrogen or C.sub.2-7 alkoxycarbonyl at the same time and that when one of R.sub.1 and R.sub.2 is hydrogen, the other is not C.sub.2-7 alkoxycarbonyl, or a pharmaceutically acceptable acid addition salt, process for preparing the derivative, and a pharmaceutical composition containing the derivative.

    摘要翻译: 本发明提供了一种下式的青霉素衍生物,其中R1和R2相同或不同,代表氢,C1-6烷基,C1-6羟烷基,C3-9酰氧基烷基,C8-13苄氧基烷基,C2-7烷氧基烷基, C 2-8烷氧基羰基,C 3-8烯氧基羰基,C 3-8炔氧基羰基,苯基,氨基,氰基,甲酰基,三氟甲基,C 2-6酰基,氨基甲酰基,C 2-7烷基氨基甲酰基,苄氧基羰基氨基,C 2-7烷氧基羰基氨基; 并且R 3是氢,用于形成药学上可接受的盐的基团或青霉素羧基保护基,条件是R 1和R 2同时不是氢或C 2-7烷氧基羰基,并且当R 1和R 2之一 是氢,另一个不是C 2-7烷氧基羰基,或其药学上可接受的酸加成盐,制备衍生物的方法和含有该衍生物的药物组合物。

    Penicillin derivatives
    2.
    发明授权
    Penicillin derivatives 失效
    青霉素衍生物

    公开(公告)号:US4562073A

    公开(公告)日:1985-12-31

    申请号:US519491

    申请日:1983-08-01

    CPC分类号: C07D499/00 C07F7/10

    摘要: A penicillin derivative represented by the following formula ##STR1## wherein R.sub.1 is hydrogen or trialkylsilyl; R.sub.2 is hydrogen, trialkylsilyl or COOR.sub.2 ' wherein R.sub.2 ' is hydrogen, C.sub.1-18 alkyl, C.sub.2-7 alkoxymethyl, C.sub.3-8 alkylcarbonyloxymethyl, C.sub.4-9 alkylcarbonyloxyethyl, (C.sub.5-7 cycloalkyl)carbonyloxymethyl, C.sub.9-14 benzylcarbonyloxyalkyl, C.sub.3-8 alkoxycarbonylmethyl, C.sub.4-9 alkoxycarbonylethyl, phthalidyl, crotonolacton-4-yl, .gamma.-butyrolacton-4-yl, halogenated C.sub.1-6 alkyl substituted with 1 to 3 halogen atoms, C.sub.1-6 alkoxy- or nitro-substituted or unsubstituted benzyl, benzhydryl, tetrahydropyranyl, dimethylaminoethyl, dimethylchlorosilyl, trichlorosilyl, (5-substituted C.sub.1-6 alkyl or phenyl or unsubstituted-2-oxo-1,3-dioxoden-4-yl)methyl, C.sub.8-13 benzoyloxyalkyl or group for forming a pharmaceutically acceptable salt; and R.sub.3 has the same meaning as above R.sub.2 '.

    摘要翻译: 由下式(IMAGE)表示的青霉素衍生物,其中R1是氢或三烷基甲硅烷基; R2是氢,三烷基甲硅烷基或COOR2',其中R2'是氢,C1-18烷基,C2-7烷氧基甲基,C3-8烷基羰氧基甲基,C4-9烷基羰氧基乙基,(C5-7环烷​​基)羰基氧基甲基,C9-14苄基羰氧基烷基,C3-8 烷氧基羰基甲基,C4-9烷氧基羰基乙基,苯酞基,巴豆酸内酯-4-基,γ-丁内酯-4-基,被1至3个卤素原子取代的卤代C 1-6烷基,C 1-6烷氧基或硝基取代或未取代的苄基,二苯甲基 ,四氢吡喃基,二甲基氨基乙基,二甲基氯甲硅烷基,三氯甲硅烷基,(5-取代的C 1-6烷基或苯基或未取代的-2-氧代-1,3-二氧杂环己烯-4-基)甲基,C8-13苯甲酰氧基烷基或用于形成药学上可接受的盐 ; 和R3具有与上述R2'相同的含义。

    Penam derivatives
    3.
    发明授权
    Penam derivatives 失效
    Penam衍生物

    公开(公告)号:US4626384A

    公开(公告)日:1986-12-02

    申请号:US716948

    申请日:1985-03-28

    CPC分类号: C07D499/00

    摘要: This invention provides a penam derivative represented by the formula ##STR1## wherein R is hydrogen or methyl and R.sub.1 is (hexahydro-1H-azepin-1-yl)methyleneamino, 2-phenylacetamido, 2-phenoxyacetamido, 2-amino-2-phenylacetamido, 2-amino-2-(p-hydroxyphenyl)acetamido or 2-(4-ethyl-2,3-dioxo-1-piperazine)carboxamido-2-phenylacetamido, and a salt thereof, and processes for preparing them.

    摘要翻译: 本发明提供由式(I)表示的对苯二甲酸衍生物,其中R是氢或甲基,R 1是(六氢-1H-吖庚因-1-基)亚甲基氨基,2-苯基乙酰氨基,2-苯氧基乙酰氨基, 2-氨基-2-(对羟基苯基)乙酰氨基或2-(4-乙基-2,3-二氧代-1-哌嗪)甲酰胺基-2-苯基乙酰氨基及其盐及其制备方法 。

    Process for producing isoxazole derivatives
    4.
    发明授权
    Process for producing isoxazole derivatives 失效
    异恶唑衍生物的制备方法

    公开(公告)号:US5310926A

    公开(公告)日:1994-05-10

    申请号:US121557

    申请日:1993-09-16

    IPC分类号: C07D261/08

    CPC分类号: C07D261/08

    摘要: The present invention provides a process for producing isoxazole derivatives represented by the formula ##STR1## wherein R.sup.1 and R.sup.2 are the same or different and are each a hydrogen atom or lower alkoxyl, and R.sup.3 is cyano or alkoxycarbonyl, the process being characterized by oxidizing an .alpha., .beta.-unsaturated ketoxime derivative represented by the formula ##STR2## wherein R.sup.1 , R.sup.2 and R.sup.3 are as defined above. The isoxazole derivatives (II) to be produced by the process of the present invention are useful as intermediates for preparing (3,4-diarylisoxazol-5-yl) acetic acid derivatives which are useful as anti-inflammatory agents, analgesics and antipyretics.

    摘要翻译: 本发明提供一种制备由式(II)表示的异恶唑衍生物的方法,其中R 1和R 2相同或不同,各自为氢原子或低级烷氧基,R 3为氰基或烷氧基羰基,该方法的特征在于 通过氧化由式(I)表示的α,β-不饱和酮肟衍生物,其中R 1,R 2和R 3如上所定义。 通过本发明的方法生产的异恶唑衍生物(II)可用作制备(3,4-二芳基异恶唑-5-基)乙酸衍生物的中间体,其可用作抗炎剂,止痛剂和解热药。

    .alpha., .beta.-unsaturated ketones and ketoxime derivatives
    5.
    发明授权
    .alpha., .beta.-unsaturated ketones and ketoxime derivatives 失效
    (ALPHA),(BETA) - 饱和的酮和酮替代衍生物

    公开(公告)号:US5142091A

    公开(公告)日:1992-08-25

    申请号:US690939

    申请日:1991-07-10

    摘要: The present invention provides an .alpha., .beta.-unsaturated ketone and ketoxime derivative represented by the formula ##STR1## wherein Y is oxygen atom or hydroxyimino group, Z is cyano or alkoxycarbonyl group, R.sup.1 and R.sup.2 are the same or different and are each hydrogen atom or lower alkoxyl group.The .alpha., .beta.-unsaturated ketones and ketoxime derivatives of the invention are useful as an intermediate for preparing a (3,4-diarylisoxazol-5-yl)acetic acid derivatives which is useful as an anti-inflammatory agent, analgesic and antipyretic.

    摘要翻译: PCT No.PCT / JP90 / 01512 Sec。 371日期:1991年7月10日 102(e)日期1991年7月10日PCT 1990年11月19日PCT PCT。 公开号WO91 / 07374 日本1991年5月30日。本发明提供由式(I)表示的+60,β-不饱和酮和酮肟衍生物,其中Y是氧原子或羟基亚氨基,Z是氰基或烷氧基羰基,R1和R2 相同或不同,为氢原子或低级烷氧基。 本发明的α,β-不饱和酮和酮肟衍生物可用作制备(3,4-二芳基异恶唑-5-基)乙酸衍生物的中间体,其可用作抗炎剂,镇痛和解热。

    Process for preparing oxytitanium phthalocyanine
    8.
    发明授权
    Process for preparing oxytitanium phthalocyanine 失效
    氧钛酞菁的制备方法

    公开(公告)号:US4777251A

    公开(公告)日:1988-10-11

    申请号:US43047

    申请日:1987-04-27

    IPC分类号: C09B47/067 C09B67/50

    CPC分类号: C09B67/0026 C09B47/067

    摘要: An improved process for preparing oxytitanium phthalocyanine is provided wherein the condensation reaction of o-phthalodinitrile with titanium tetrachloride is effected in an organic solvent at 170.degree. to 300.degree. C. followed by hydrolysis, the improvement wherein said organic solvent is preliminarily heated at a temperature of 160.degree. to 300.degree. C. prior to initiation of the condensation reaction. The A form of oxytitanium phthalocyanine crystal can selectively be produced in the pure state.

    摘要翻译: 提供了一种制备氧钛酞菁的改进方法,其中邻苯二甲腈与四氯化钛的缩合反应在有机溶剂中在170℃至300℃下进行,然后进行水解,其改进在于所述有机溶剂在温度 在开始缩合反应之前为160℃至300℃。 氧化钛酞菁晶体的A形式可以选择性地以纯态生产。

    Silver halide photosensitive photographic material
    9.
    发明授权
    Silver halide photosensitive photographic material 失效
    卤化银感光感光材料

    公开(公告)号:US4399213A

    公开(公告)日:1983-08-16

    申请号:US312136

    申请日:1981-10-16

    摘要: A silver halide photosensitive material comprising a support, a silver halide photosensitive layer, and a protective layer formed on said support. The protective layer is essentially composed on a plurality of non-photosensitive hydrophilic colloidal layers at least one of which contains oil particles. The outermost layer of the hydrophilic colloidal layers contains a matting agent in the form of colloidal particles and has a thickness of not more than one fourth of the average size of the matting agent particles and wherein the density of the oil particles in said outermost layer does not exceed 0.2 by volume of the binder, and that of the oil particles in the protective layers other than the outermost layer is in the range of 0.1 to 0.8.

    摘要翻译: 一种卤化银感光材料,其包括载体,卤化银感光层和形成在所述载体上的保护层。 保护层基本上由多个非感光亲水性胶体层构成,其中至少一个含有油颗粒。 亲水性胶体层的最外层含有胶体颗粒形式的消光剂,其厚度不超过消光剂颗粒的平均尺寸的四分之一,其中所述最外层中的油颗粒的密度为 不超过粘合剂体积的0.2体积,除了最外层以外的保护层中的油粒子的比例在0.1〜0.8的范围内。

    3′-ethynylcytidine derivative
    10.
    发明授权
    3′-ethynylcytidine derivative 失效
    3'-乙炔基胞苷衍生物

    公开(公告)号:US08058261B2

    公开(公告)日:2011-11-15

    申请号:US12375077

    申请日:2007-07-23

    IPC分类号: A01N43/04 A61K31/70

    CPC分类号: C07H19/06

    摘要: To provide a compound which exhibits excellent anti-tumor activity and excellent oral absorption and which is a useful anti-tumor drug.The invention provides a 3′-ethynylcytidine derivative represented by formula (1): (wherein X represents a (substituted) alkylcarbonyl group, a (substituted) alkoxycarbonyl group, or a hydrogen atom; one of Y and Z represents a hydrogen atom or a group represented by (R1)(R2)(R3)Si— and the other represents a group represented by (R4)(R5)(R6)Si—; and R1, R2, R3, R4, R5, and R6 each represent a (substituted) alkyl group, a (substituted) cyclic alkyl group, or a (substituted) aryl group) or a salt thereof.

    摘要翻译: 提供表现出优异的抗肿瘤活性和优异的口服吸收并且是有用的抗肿瘤药物的化合物。 本发明提供由式(1)表示的3'-乙炔基胞苷衍生物:其中X表示(取代)烷基羰基,(取代)烷氧基羰基或氢原子; Y和Z之一表示氢原子或 (R 1)(R 2)(R 3)Si表示的基团,另一个表示由(R 4)(R 5)(R 6)Si - 表示的基团,R 1,R 2,R 3,R 4,R 5和R 6各自表示 (取代的)烷基,(取代的)环烷基或(取代的)芳基)或其盐。